Synthesize Bio, a biotechnology company pioneering biological foundation models to simulate the results of gene expression ...

The Seattle-based biotech company aims to make new drug discovery faster and cheaper by using AI to simulate the results from ...

Extension financing led by new investor Bpifrance, with renewed participation from all existing shareholders, AdBio Partners, CDTI Innovación, ...

AecorBio Inc., formerly known as HBC Immunology Inc, has successfully completed a further equity financing round of $1.5m from existing and new investors at a company valuation of $30 million. This ...

Cas9 modifications to the TcNPR3 gene in cacao reduce Phytophthora susceptibility, supporting eco-friendly agricultural practices.

Transplanted mouse and human organoids showed kidney-like functions like blood filtration, protein uptake, and urine production.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Groundbreaking achievements include successfully grown Pigeon Primordial Germ Cells (PGCs), gene edited chicken surrogates, ...

Biostate AI has officially launched K-Dense Beta, an advanced multi-agent artificial intelligence system designed to ...

Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

Researchers in Berlin have used base editing to repair mutations that cause the kidney disorder ADPKD in cells from both mice ...

A genome-editing technique known as prime editing holds potential for treating many diseases by transforming faulty genes into functional ones. However, the process carries a small chance of inserting ...